vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2019-4-7-13vtio-1101Research ArticleТРАНСПЛАНТАЦИЯ ОРГАНОВORGAN TRANSPLANTATIONТрансплантация сердца у реципиентов с исходной легочной гипертензией: 9-летний опыт НМИЦ имени В.А. АлмазоваBaseline pulmonary hypertension in heart transplant recipients: 9 years of experience at Almazov National Medical Research CentreСимоненкоМ. А.SimonenkoM. A.

Симоненко Мария Андреевна

197341, Санкт-Петербург, ул. Аккуратова, д. 2.Тел. (921) 952-43-55.

 

Simonenko Maria Andreevna

2, Akkuratova str., Saint-Petersburg, 197341Tel. (921) 952-43-55

 

dr.maria.simonenko@gmail.comНиколаевГ. В.NikolayevG. V.

Санкт-Петербург

St. Petersburg

МаликовК. Н.MalikovK. N.

Санкт-Петербург

St. Petersburg

ФедотовП. А.FedotovP. A.

Санкт-Петербург

St. Petersburg

СазоноваЮ. В.SazonovaY. V.

Санкт-Петербург

St. Petersburg

БорцоваМ. А.BortsovaM. A.

Санкт-Петербург

St. Petersburg

РубинчикВ. Е.RubinchikV. E.

Санкт-Петербург

St. Petersburg

МаричевА. О.MarichevA. O.

Санкт-Петербург

St. Petersburg

БаутинА. Е.BautinA. E.

Санкт-Петербург

St. Petersburg

СитниковаМ. Ю.SitnikovaM. Y.

Санкт-Петербург

St. Petersburg

ГордеевМ. Л.GordeevM. L.

Санкт-Петербург

St. Petersburg

КарпенкоМ. А.KarpenkoM. A.

Санкт-Петербург

St. Petersburg

ФГБУ «Национальный медицинский исследовательский центр имени В.А. Алмазова» Минздрава РоссииРоссияAlmazov National Medical Research CentreRussian Federation201931012020214713Copyright © Симоненко М.А., Николаев Г.В., Маликов К.Н., Федотов П.А., Сазонова Ю.В., Борцова М.А., Рубинчик В.Е., Маричев А.О., Баутин А.Е., Ситникова М.Ю., Гордеев М.Л., Карпенко М.А., 20202020Симоненко М.А., Николаев Г.В., Маликов К.Н., Федотов П.А., Сазонова Ю.В., Борцова М.А., Рубинчик В.Е., Маричев А.О., Баутин А.Е., Ситникова М.Ю., Гордеев М.Л., Карпенко М.А.Simonenko M.A., Nikolayev G.V., Malikov K.N., Fedotov P.A., Sazonova Y.V., Bortsova M.A., Rubinchik V.E., Marichev A.O., Bautin A.E., Sitnikova M.Y., Gordeev M.L., Karpenko M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1101трансплантация сердцасердечная недостаточностьлегочная гипертензиядавление в легочной артериилегочное сосудистое сопротивлениевазодилататорыheart transplantationheart failurepulmonary hypertensionPHpulmonary artery pressurePAPpulmonary vascular resistancePVRvasodilatorsReferencesGalie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al. 2015 ESC/ERC Guidelines for the diagnosis and treatment of pulmonary hypertension, European Society of Cardiology / European Respiratory Society. Eur Heart J. 2016; 37: 67–119. doi: 10.1093/eurheartj/ehv317.Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al. 2015 ESC/ERC Guidelines for the diagnosis and treatment of pulmonary hypertension, European Society of Cardiology / European Respiratory Society. Eur Heart J. 2016; 37: 67–119. doi: 10.1093/eurheartj/ehv317.Roldan C. The ultimate echo guide. Lippincott Williams and Wilkins, 2005. PMCID: PMC2650657.Roldan C. The ultimate echo guide. Lippincott Williams and Wilkins, 2005. PMCID: PMC2650657.Delgado JF, Gomez-Sanchez MA, Saenz de la Calzada C, Sanchez V, Escribano SV, Hernandez-Afonso et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. Journal of Heart Lung Transplantation. 2001; 20: 942–948. PMID: 11557188. doi: 10.1016/s10532498(01)00286-8.Delgado JF, Gomez-Sanchez MA, Saenz de la Calzada C, Sanchez V, Escribano SV, Hernandez-Afonso et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. Journal of Heart Lung Transplantation. 2001; 20: 942–948. PMID: 11557188. doi: 10.1016/s10532498(01)00286-8.Deng MC, Gradaus R, Hammel D, Weyand M., Gunther F, Kerber S et al. Heart Transplant candidates at high risk can be identified at the time of initial evaluation. Transplantat International. 1996; 9 (1): 38–45. PMID: 8748409. doi: 10.1007/bf00336810.Deng MC, Gradaus R, Hammel D, Weyand M., Gunther F, Kerber S et al. Heart Transplant candidates at high risk can be identified at the time of initial evaluation. Transplantat International. 1996; 9 (1): 38–45. PMID: 8748409. doi: 10.1007/bf00336810.Ross H, Hendry P, Dipchand A, Giannetti N, Hirsch G, Isaac D et al. Canadian Cardiovascular Society Consensus Conference on cardiac transplantation. Canadian Journal of Cardiology. 2003; 19: 620–654. PMCID: PMC2706756.Ross H, Hendry P, Dipchand A, Giannetti N, Hirsch G, Isaac D et al. Canadian Cardiovascular Society Consensus Conference on cardiac transplantation. Canadian Journal of Cardiology. 2003; 19: 620–654. PMCID: PMC2706756.Kettner A, Dorazilova Z, Netuka I, Maly J, Al-hiti H, Melenovsky V et al. Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more. Physiol Res. 2011; 60 (5): 769–775. PMID: 21812520.Kettner A, Dorazilova Z, Netuka I, Maly J, Al-hiti H, Melenovsky V et al. Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more. Physiol Res. 2011; 60 (5): 769–775. PMID: 21812520.Klotz S, Wenzelburger F, Stypmann J, Welp H, Drees G, Schmid C et al. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. The annals of thoracic surgery. 2006; 82 (5): 1770–1773. doi: 10.1016/j.athoracsur.2006.05.114.Klotz S, Wenzelburger F, Stypmann J, Welp H, Drees G, Schmid C et al. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. The annals of thoracic surgery. 2006; 82 (5): 1770–1773. doi: 10.1016/j.athoracsur.2006.05.114.Hill NS, Roberts KR, Preston IR. Postoperative Pulmonary Hypertension: Etiology and Treatment of a Dangerous Complication. Respiratory Care. 2009; 54 (7): 958–968. PMID: 19558745.Hill NS, Roberts KR, Preston IR. Postoperative Pulmonary Hypertension: Etiology and Treatment of a Dangerous Complication. Respiratory Care. 2009; 54 (7): 958–968. PMID: 19558745.Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe lowoutput heart failure (the LIDO study): a randomized double-blind trial. Lancet. 2002; 360 (9328): 196–202. PMID: 12133653.Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe lowoutput heart failure (the LIDO study): a randomized double-blind trial. Lancet. 2002; 360 (9328): 196–202. PMID: 12133653.Mogollon Jimenez MV, Escoresca Prtega AM, Cabeza Letran ML, Hinojosa Perez R, Galle EL, Sobrino Marquez JM et al. Correlation of Echocardiographic and Hemodynamic Parameters in Pulmonary Hypertension Assessment Prior to Heart Transplantation. Transplantation Proceedings. 2008; 40: 3023–3024. doi: 10.1016/j.transproceed.2008.09.044.Mogollon Jimenez MV, Escoresca Prtega AM, Cabeza Letran ML, Hinojosa Perez R, Galle EL, Sobrino Marquez JM et al. Correlation of Echocardiographic and Hemodynamic Parameters in Pulmonary Hypertension Assessment Prior to Heart Transplantation. Transplantation Proceedings. 2008; 40: 3023–3024. doi: 10.1016/j.transproceed.2008.09.044.Zeng Z, Jiang Z, Wang CS, Luo H, Huang YF, Jin XH. Preoperative Evaluation Improves the Outcome in Heart Transplant Recipients With Pulmonary Hypertension Retrospective Analysis of 106 Cases. Transplantation Proceedings by ELSEVIER. 2010; 42: 3708–3710. doi: 10.1016/j.transproceed.2010.08.067.Zeng Z, Jiang Z, Wang CS, Luo H, Huang YF, Jin XH. Preoperative Evaluation Improves the Outcome in Heart Transplant Recipients With Pulmonary Hypertension Retrospective Analysis of 106 Cases. Transplantation Proceedings by ELSEVIER. 2010; 42: 3708–3710. doi: 10.1016/j.transproceed.2010.08.067.Klotz S, Deng MC, Hanafy D, Schmid C, Stypmann J, Schmidt C et al. Reversible pulmonary hypertension in heart transplant candidates – pretransplant evalution and outcome after orthotopic heart transplantation. The European Journal of Heart Failure. 2003; 5: 645–653. doi: 10.1016/S1388-9842(03)00059-X.Klotz S, Deng MC, Hanafy D, Schmid C, Stypmann J, Schmidt C et al. Reversible pulmonary hypertension in heart transplant candidates – pretransplant evalution and outcome after orthotopic heart transplantation. The European Journal of Heart Failure. 2003; 5: 645–653. doi: 10.1016/S1388-9842(03)00059-X.Drakos SG, Kfoure AG, Gilbert EM, Horne BD, Long JW, Strangham JC et al. Effect of reversible pulmonary hypertension on outcomes after heart transplantation. The Journal of Heart and Lung Transplantation. 2007; 26 (4): 319–323. doi: 10.1016/j.healun.2007.01.012.Drakos SG, Kfoure AG, Gilbert EM, Horne BD, Long JW, Strangham JC et al. Effect of reversible pulmonary hypertension on outcomes after heart transplantation. The Journal of Heart and Lung Transplantation. 2007; 26 (4): 319–323. doi: 10.1016/j.healun.2007.01.012.Gude E, Simonsen S, Geiran OR, Fiane AE, Gullestad L, Arora S et al. Pulmonary hypertension in heart transplantation: Discrepant prognostic impact of pre-operative compared with 1-year post-operative right heart hemodynamics. The Journal of Heart and Lung Transplantation. 2010; 29 (2): 216–223. doi: 10.1016/j.healun.2009.08.021.Gude E, Simonsen S, Geiran OR, Fiane AE, Gullestad L, Arora S et al. Pulmonary hypertension in heart transplantation: Discrepant prognostic impact of pre-operative compared with 1-year post-operative right heart hemodynamics. The Journal of Heart and Lung Transplantation. 2010; 29 (2): 216–223. doi: 10.1016/j.healun.2009.08.021.Lindelow B, Andersson B, Waagstein F, Bergh CH. High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. European Heart Journal. 1999; 20: 148–156. PMID: 10099912.Lindelow B, Andersson B, Waagstein F, Bergh CH. High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. European Heart Journal. 1999; 20: 148–156. PMID: 10099912.Kitamura S, Nakatani T, Kato T, Yanase M, Kobayashi J, Nakajima H et al. Hemodynamic and Echocardiographic Evaluation of Orthotopic Heart Transplantation with the modified bicaval anastomosis technique. Circulation Journal. 2009; 73 (7): 1235–1239. PMID: 19398842. doi: 10.1253/circj.cj-08-1098.Kitamura S, Nakatani T, Kato T, Yanase M, Kobayashi J, Nakajima H et al. Hemodynamic and Echocardiographic Evaluation of Orthotopic Heart Transplantation with the modified bicaval anastomosis technique. Circulation Journal. 2009; 73 (7): 1235–1239. PMID: 19398842. doi: 10.1253/circj.cj-08-1098.Баутин АЕ, Яковлев АС, Заяшников СВ, Ташханов ДМ, Маричев АО, Федотов ПА и др. Сравнение гемодинамических эффектов ингаляционного илопроста и оксида азота при назначении пациентам с выраженной систолической дисфункцией левого желудочка. Российский кардиологический журнал. 2017; 12 (152): 97–103. doi: 10.15829/1560-4071-201712-97-103.Bautin AE, Yakovlev AS, Zayashnikov SV, Tashkhanov DM, Marichev AO, Fedotov PA et al. Comparison of hemodynamic effects of inhalatory iloprost and nitroc oxide in patients with sever left ventricle dysfunction. Russ J Cardiol. 2017, 12 (152): 97–103. doi: 10.15829/1560-4071-2017-12-97-103.Борцова МА, Баутин АЕ, Яковлев АС, Федотов ПА, Сазонова ЮВ, Маричев АО и др. О возможности повышения информативности диагностики необратимой легочной гипертензии у кандидатов на трансплантацию сердца. Альманах клинической медицины. 2019; 47 (3): 212–220. doi: 10.18786/2072-0505-201947-030.Bortsova MA, Bautin AE, Yakovlev AS, Fedotov PA, Sazonova YuV, Marichev AO et al. On the possibility to increase sensitivity of diagnostic tests for fixed pulmonary hypertension in heart transplant candidates. Almanac of Clinical Medicine. 2019; 47 (3): 212–220. doi: 10.18786/2072-0505-2019-47-030.Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasckaran K et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A report from the American society of echocardiography. Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. Journal American Society of Echocardiology. 2010; 23: 685–713. PMID: 20620859. doi: 110.1016/j.echo.2010.05.010.Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasckaran K et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A report from the American society of echocardiography. Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. Journal American Society of Echocardiology. 2010; 23: 685–713. PMID: 20620859. doi: 110.1016/j.echo.2010.05.010.Wong RC, Abrahams Z, Hanna M, Pangrace J, Gonzalez-Stawinski G, Starling R et al. Tricuspid Regurgitation after Cardiac Transplantation: An Old Problem Revisited. Journal of Heart and Lung Transplantation. 2008; 27 (3): 247–252. doi: 10.1016/j.healun.2007.12.011.Wong RC, Abrahams Z, Hanna M, Pangrace J, Gonzalez-Stawinski G, Starling R et al. Tricuspid Regurgitation after Cardiac Transplantation: An Old Problem Revisited. Journal of Heart and Lung Transplantation. 2008; 27 (3): 247–252. doi: 10.1016/j.healun.2007.12.011.Barst RJ, Galle N, Naelje R, Simonneau G, Jeffs R, Arneson C et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. European Respiratory Journal. 2006; 28: 11951203. doi: 10.1183/09031936.06.00044406.Barst RJ, Galle N, Naelje R, Simonneau G, Jeffs R, Arneson C et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. European Respiratory Journal. 2006; 28: 11951203. doi: 10.1183/09031936.06.00044406.Шемакин СЮ, Халилулин ТА, Федосеева АА. Недостаточность трикуспидального клапана после ортотопической трансплантации сердца. Вестник трансплантологии и искусственных органов. 2009; 11 (2): 21–24.Shemakin SY, Khalilulin TA, Fedoseeva AA. Tricuspid valve dysfunction after orthotopic heart transplantation. Russian Journal of Transplantology and Artificial Organs. 2009; 11 (2): 21–34.Mogollon MV, Galle EL, Perez RH, Aviles AH, Sobrino Marquez JM, Rodriguez NR et al. Prognosis after Heart Transplant in Patients with Pulmonary Hypertension Secondary to Cardiopathy. Transplantation Proceedings. 2008; 40: 3031–3033. doi: 10.1016/j.transproceed.2008.09.051.Mogollon MV, Galle EL, Perez RH, Aviles AH, Sobrino Marquez JM, Rodriguez NR et al. Prognosis after Heart Transplant in Patients with Pulmonary Hypertension Secondary to Cardiopathy. Transplantation Proceedings. 2008; 40: 3031–3033. doi: 10.1016/j.transproceed.2008.09.051.Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M et al. Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension. Plos One. 2017; 13 (12): 1–10. doi: 10.1371/journal.pone.0188383.Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M et al. Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension. Plos One. 2017; 13 (12): 1–10. doi: 10.1371/journal.pone.0188383.Al-Hiti H, Melenovsky V, Syrovatka P, Kettner J, Malek I, Kautzner J. Sildenafil is more selective pulmonary vasodilator than Prostaglandin E1 in Patients with Pulmonary Hypertension Due to Heart Failure. Physiol Res. 2011; 60: 303–308. ISSN 1802-9973.Al-Hiti H, Melenovsky V, Syrovatka P, Kettner J, Malek I, Kautzner J. Sildenafil is more selective pulmonary vasodilator than Prostaglandin E1 in Patients with Pulmonary Hypertension Due to Heart Failure. Physiol Res. 2011; 60: 303–308. ISSN 1802-9973.Seferian A, Simonneau G. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? European Respiratory Revision. 2013; 22: 217–226. doi: 10.1183/09059180.00001713.Seferian A, Simonneau G. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? European Respiratory Revision. 2013; 22: 217–226. doi: 10.1183/09059180.00001713.

The authors declare that there are no conflicts of interest present.